Stock CBMG CELLULAR BIOMEDICINE GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Other languages Cellular Biomedicine Group, Inc.

Equities

CBMG

US15117P1021

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nektar Therapeutics Announces New Clinical Study Collaboration with Cellular Biomedicine Group Inc. to Evaluate Nktr-255 in Combination with C-Til051 in Advanced Non-Small Cell Lung Cancer
Cellular Biomedicine Group Announces FDA Clearance of Investigational New Drug Application for Novel TIL Therapy C-TIL051
Cellular Biomedicine Group Inc Receives FDA Regenerative Medicine Advanced Therapy and Fast Track Designations for Bi-Specific Anti-CD19/CD20 CAR-T Cell Therapy for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Cellular Biomedicine : Completes Merger with CBMG Holdings; Shares to No Longer Trade on Nasdaq
Cellular Biomedicine Group, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
Cellular Biomedicine Group, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CBMG Stock
  4. News Cellular Biomedicine Group, Inc.
  5. Other languages